Interní Med. 2008; 10(1): 19-24

Cholelithiasis

prof. MUDr. Jiří Ehrmann CSc
II. interní klinika FN a LF UP Olomouc

Gallstones, cholelithiasis and choledocholithiasis are a common and costly health problem in the world. The prevalence of gallstones is approximately 10 % and increases with age in all racial groups. The description of the principles of cholesterol solubility and cholesterol supersaturation was fundamental for understanding of a cholesterol gallstone formation. The prevalence of cholesterol or mixed gallstones ranges around 90 % or 10 % of pigment gallstones respectively. Asymptomatic cholelithiasis ranges from 30 to 70 %. The typical symptoms of gallstones are biliary indigestion and biliary colic, on the other hand cholecystitis and cholangitis are the most often complications. Cholestasis the concomitant syndrom of choledocholithiasis constitutes a general differential diagnostic medical problem. There are no laboratory tests to differ extrahepatic from intrahepatic cholestasis. This is the main reason for so many imaging diagnostic methods for example USG, ERCP and others. Laparoscopic cholecystektomy is an usual treatment of cholecystolithiasis (with acute and chronic cholecystitis), ERCP for removing of stones in choledocholithiasis. Dissolution therapy (oral bile acids – chenodeoxycholic or ursodeoxycholic acids) has limited value, except in patients who are poor candidates for surgery.

Keywords: ates for surgery. Key words:

Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehrmann J. Cholelithiasis. Interní Med. 2008;10(1):19-24.
Download citation

References

  1. Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47: 1043-1052. Go to original source... Go to PubMed...
  2. Černoch J. Léčba obtížné choledocholitiázy. In: Zavoral M, Dítě P, Špičák J, Bureš J, a kol. Nové trendy v digestivní endoskopické diagnostice a léčbě. Praha: Grada Publishing 2000: 165-176.
  3. Ehrmann J, Procházka V, Schneiderka P. Diferenciální diagnostika ikteru. Postgrad Med 2001; 3: 912-916.
  4. Hofmann AF. Gallstone disease: physicochemical research sheds new ligt on an old disease and points the way to medical therapy. J Hepatol 2004; 41: 195-200. Go to original source... Go to PubMed...
  5. Kojecký Z, Ehrmann J, Güttnerová J. Žlučové kameny ve stáří. Vnitřní lékařství 1978; 24: 604-507. Go to PubMed...
  6. Mareček Z. Cholelitiáza a ostatní nenádorové nemoci žlučového ústrojí. In: Mařatka Z. Gastroenterologie. Praha: Nakladatelství Karolinum 1999: 345-361.
  7. Persley KM, Jain R. Gallstones and biliary tract disease. ACP Medicine 2005; 5: 1-11.
  8. Procházka V. Diagnostický postup u ikterických stavů; Zobrazovací metody. In: Ehrmann J. a kol. Ikterus - diferenciální diagnostika. Praha: Grada Publishing 2003: 68-84.
  9. Procházka V. Žlučové kameny. In: Ehrmann J. a kol. Ikterus - diferenciální diagnostika. Praha: Grada Publishing 2003: 203-210.
  10. Procházka V, Koďousek R, Krausová V, Zámečníková P. Foreign material as a cause of choledocholithiasis. Endoscopy 1999; 31: 383-385. Go to original source... Go to PubMed...
  11. Procházka V, Krč I, Zámečníková P. Les complications biliaires des anémies hémolytiques pendant l´enfance. Acta Endoscop 1999; (Suppl 2): 433. Go to original source...
  12. Sherlock S, Dooley J. Gallstones and biliary tract disease. In: Diseases of the liver and biliary system. London: Blackwell Science Ltd and Blackwell Publishing Company 2002: 597-628.
  13. Silbernagl S, Despiopoulos A. Vylučovací funkce jater, tvorba žluči, žloutenka. In: Atlas fyziologie člověka. Praha: Grada Publishing 1993: 214-217.
  14. Šmajstrla V, Ehrmann J, Matoušková I. Colicinogeny in patients after cholecystectomy. Acta Univ. Palacki Olomus Fac Med 1988; 120: 245-249.
  15. Thomayer J. Žluční kameny. Cholelithiasis. In: Pathologie a Therapie Nemocí Vnitřních. Praha: Nakladatelství Bursík & Kohout 1921: 930-937.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.